|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| Information provided by: | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| ClinicalTrials.gov Identifier: | NCT00059670 |
Purpose
The aim of this research study is to determine the effectiveness of: 1) a traditional therapy regimen focusing on individual exercises for pharyngeal (throat) and laryngeal (voice box) musculature and 2) a new therapeutic exercise, the Shaker exercise.
The primary objective of this 5-year project is to identify which of two therapy programs, the Shaker exercise versus traditional therapy, results in the largest number of stable, non-oral dysphagic patients who can swallow safely and return to full oral feeding after 6 weeks of intervention. The study is powered adequately so that this aim can be tested separately for head and neck cancer and stroke patients. Our primary outcome measure is return to oral feeding, i.e., 100% of nutrition and hydration by mouth.
| Condition | Intervention |
|
Deglutition Disorders |
Procedure: Shaker Exercise vs. Traditional Dysphagia Therapy Regime |
| MedlinePlus related topics: | Exercise and Physical Fitness Swallowing Disorders |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Efficacy Study |
| Official Title: | Comparison of Two Therapies for UES Dysphagia |
| Estimated Enrollment: | 204 |
| Study Completion Date: | December 2007 |
Secondary aims of this research are:
Define the pathophysiology underlying the swallow dysfunction and those pathophysiologic elements which change as a result of each therapy program including changes in -
Eligibility
| Ages Eligible for Study: | 21 Years to 90 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria (all required)
Exclusion Criteria
bensodiazopin, antihistamines
Contacts and Locations| United States, Wisconsin | |||||
| Medical College University of Wisconsin | |||||
| Milwaukee, Wisconsin, United States | |||||
| Principal Investigator: | Reza Shaker, M.D. | Professor and Chief, Division of Gastroenterology and Hepatology, Director, Digestive Disease Center, Medical College of Wisconsin |
| Principal Investigator: | Jerilyn A. Logemann, Ph.D. | Professor Department of Communication Sciences and Disorders, Ralph and Jean Sundin Professor of Communication Sciences and Disorders, Northwestern University |
More Information
Division of Gastroenterology and Hepatology 
  |
| Study ID Numbers: | UESD |
| First Received: | May 1, 2003 |
| Last Updated: | January 30, 2008 |
| ClinicalTrials.gov Identifier: | NCT00059670 |
| Health Authority: | United States: Federal Government |
|
|
|